Open AccessAssociation Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone
Author(s) -
Kristian F. Axelsson,
Anna G Nilsson,
Hans Wedel,
Dan Lundh,
Mattias Lorentzon
Publication year - 2017
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.8040
Subject(s) - medicine , prednisolone , retrospective cohort study , interquartile range , incidence (geometry) , hip fracture , propensity score matching , cohort study , cohort , adverse effect , surgery , osteoporosis , physics , optics
Oral glucocorticoid treatment increases fracture risk, and evidence is lacking regarding the efficacy of alendronate to protect against hip fracture in older patients using glucocorticoids.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom